From: Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
Study group “TXA” (n=50) | Control group “placebo” (n=50) | P | |
---|---|---|---|
Lost RBCV | |||
Range | 83–193 | 131–325 | <0.001** |
Mean±SD | 138.92±29.73 | 230.92±45.73 | |
Blood loss | |||
Range | 250–579 | 393–975 | <0.001** |
Mean±SD | 416.12±89.95 | 688.68±134.77 |